|
Getting your Trinity Audio player ready...
|
On Wednesday, the UK medicines regulator the National Institute of Health and Care Excellence (“NICE”) approved the use of the weight loss drug Mounjaro on the NHS.
It’s not clear that this drug is safe in the long term so why would NICE approve it to be provided for free to potentially millions of people?
Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…
It is claimed Mounjaro, the brand name of tirzepatide, is more effective than semaglutide, known as Ozempic and Wegovy.
Writing for the Daily Mail, Dr. Renée Hoenderkamp expressed concerns that not only will the availability of the drugs at taxpayers’ expense undermine the idea that people should take responsibility for their own lifestyle choices, but it will add to the strain on the already overstretched NHS Budget.
The principle – that the NHS will bankroll irresponsible behaviour and thereby encourage it – is a troubling one, she said.
Mounjaro which costs £122 per month will initially be offered to 222,000 people, a fraction of the 3.4 million in Britain who are classified as obese. “Once the Mounjaro jab is prescribed it will be difficult, if not impossible, for the NHS to keep a lid on the numbers,” Dr. Hoenderkamp said.
If the injections were given to 3.4 million people, that would equate to nearly £415 million per month.
Additionally, she said, “it is not clear that the drug is safe in the long term and its manufacturer has yet to share full details of the research it has funded so far. Side-effects may take years, even decades to emerge, which means that this step amounts to an expensive leap into the unknown.”
So why are the NHS embarking on this madness?
Sharing her article on Twitter Dr. Hoendekamp said, “Jabs for obesity will bankrupt the NHS and bring unknown and known side effects. BUT will make big pharma wealthier than they ever imagined from one patient group!”
Her accusation is not without substance. The day before she had tweeted: “Eli Lilly (maker of the obesity Jab) has donated £279 million to a Government collaboration and what do they want in return … their jab into the NHS” and included a hyperlink to the UK government press release below.
On 14 October, the UK government announced a memorandum of understanding with Lilly. Under the agreement, the pharmaceutical giant will launch the first ‘Lilly Gateway Labs’ innovation accelerator in Europe. “This facility will support early-stage life sciences businesses to develop transformative medicines by providing lab space, mentorship and potential financial backing to rocket future growth in the sector,” the press release said. It continued:
Obesity is the second biggest preventable cause of cancer and a major contributor to ill health that prevents people from participating fully in work. This collaboration will bring together treatments and technologies developed by the life sciences sector and the health system seeking to demonstrate improved long-term health outcomes for those living with obesity.
The collaboration with Lilly aims to set the stage for government to work with industry to trial innovative approaches to treating obesity as part of a rounded package of care.
Driving economic growth to improve the lives of hardworking British people is this government’s number one mission. The life sciences sector – which drove £800 million in foreign direct investment into the UK in 2023 – sits at the heart of these plans.
Landmark collaboration with largest pharmaceutical company, UK Government, 14 October 2024
Unsurprisingly, corporate media is being used to campaign for and market Mounjaro. Pushing for more people to be offered Lilly’s weight loss injections, paid for by the NHS, The Times wrote:
NICE, the health watchdog, has ruled that 3.4 million adults are eligible for Mounjaro, the most effective so far in a revolutionary new class of anti-obesity injections. But a lack of NHS capacity means only 220,000 of these patients, fewer than one in ten, will be given the drug over the next three years, after spending years on waiting lists.
Most obese people will instead be directed to the NHS app offering weight-loss tips. NICE said they would “have to wait” for drugs in an effort to “protect other vital NHS services.” Delays in giving the jabs threaten to undermine a promise by Sir Keir Starmer to bring down waiting lists while a rise in obesity-related diseases piles pressure on the health service.
Millions of obese people will be denied weight-loss jabs on the NHS, The Times, 5 December 2024
We have attached The Times article below so you can read for yourself how hard The Times is campaigning for more people to be given these injections.
Dr. Hoendenkamp responded to The Times article. “Open your eyes … these people do not care about your health, just the money,” she said and quoted The Times as saying, “Eli Lilly, the firm that manufactures Mounjaro, urged the health service to ‘ramp up’ its introduction of weight-loss drugs.”
“This is the company who has just managed to get NICE to approve their obesity jab for the NHS …. Give a bit of money to the government, get a licence to print money …,” she added.
Further reading:
- The general public has now been firmly established as guinea pigs for Big Pharma
- Corporate media is used to advertise and lobby for the pharmaceutical industry
- The scary, startling truth about “wonder drugs” semaglutide and tirzepatide
- Another warning about the so-called miracle weight loss drugs
The Expose Urgently Needs Your Help…
Can you please help to keep the lights on with The Expose’s honest, reliable, powerful and truthful journalism?
Your Government & Big Tech organisations
try to silence & shut down The Expose.
So we need your help to ensure
we can continue to bring you the
facts the mainstream refuses to.
The government does not fund us
to publish lies and propaganda on their
behalf like the Mainstream Media.
Instead, we rely solely on your support. So
please support us in our efforts to bring
you honest, reliable, investigative journalism
today. It’s secure, quick and easy.
Please choose your preferred method below to show your support.
Categories: Breaking News
Sheep will line up for yet another jab.
Spiritually bankrupt people looking for answers in pills, potions and jabs..
Seek the Lord your God for peace and contentment…
Well said.
Thou wilt keep him in perfect peace, whose mind is stayed on Thee: because he trusteth in Thee.
Isaiah 26:3.
“As a GP, here’s why we SHOULDN’T give patients weight-loss jabs on the NHS. These risks are just too great: DR RENEE HOENDERKAMP”
https://www.dailymail.co.uk/health/article-14163315/GP-dangerous-NHS-pay-fat-jabs.html
‘It’s not clear that this drug is safe in the long term so why would NICE approve it to be?’
Because it pops holes in immune barriers, increasing access to the body. This one has the added benefit of being related with optogenetics, one of their new tricks.
Once again, the media claims stupidity in knowing if it’s safe. Semaglutide has risks, and acts as a drug delivery system. This means that they can attach other things to it, which will then be taken through the body to wherever GLP goes.
So, what does literature related to GLP say?
This one states that GLP-1 receptor agonists must pass through the BBB:
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
“Recent clinical studies reported that SGLT-2is improved hypertension and atrial fibrillation by modulating the “overstimulated” renin-angiotensin-aldosterone system (RAAS) and suppressing the sympathetic nervous system (SNS) by directly/indirectly acting on the rostral ventrolateral medulla.
Therefore, GLP-1RAs need to pass through the blood-brain barrier to exert their pharmacological effects.”
https://pubmed.ncbi.nlm.nih.gov/36035518/
This one tells us that GLP-1 increases the risk of thyroid cancer:
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
“Results: A total of 2,562 case subjects with thyroid cancers were included in the study and matched with 45,184 control subjects. Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid cancer (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) and medullary thyroid cancer (adjusted HR 1.78, 95% CI 1.04-3.05).”
https://pubmed.ncbi.nlm.nih.gov/36356111/
They really really like this area of the brain:
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers
“Recent findings from animal and human studies indicate that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) modulate stress response by activating the hypothalamic-pituitary-adrenal (HPA) axis, which may have relevant clinical implications.”
https://pubmed.ncbi.nlm.nih.gov/30272170/
As I mentioned above, semaglutide is a DDS; males watch out, if anything is attached to the Semaglutide, then it goes where semaglutide goes:
Impact of GLP-1 Agonists on Male Reproductive Health-A Narrative Review
“Results-GLP-1 receptors have been identified within the male reproductive system according to the existing literature. While the exact mechanisms are not well understood, they appear to be involved in glucose homeostasis and energy metabolism, both vital processes in spermatogenesis”
https://pubmed.ncbi.nlm.nih.gov/38256311/
They know what it does, and they know the risks of taking it. The denial is a red flag.
Here’s another red flag; Why would Goldman-Sachs equate the economy to ozempic? Because of the access to the body:
“The more Americans who take Ozempic, the faster the US economy could grow, Goldman Sachs says”
https://www.msn.com/en-us/money/economy/the-more-americans-who-take-ozempic-the-faster-the-us-economy-could-grow-goldman-sachs-says/ar-BB1iLVjT
Will these injections have the vaccine in them like the Dental Anesthetics?
Please warn everybody?
They’re cenomized and will kill your GI Tract and you, eventually. Dr Ardis explains. https://old.bitchute.com/video/7PN9PtSI7hpC/
Re: Testing procedures. The Gold standard testing procedures of pathogens are Koch’s Postulates. Koch’s postulates, first stated by the great German bacteriologist Robert Koch in the late 1800’s can be simply stated as: Purify the pathogen (e.g., disease ) from many cases with a particular illness.
Expose susceptible animals (not humans) to the pathogen. Verify by an independent study group, that the same illness is produced.
In a 1936 speech Famous virologist Thomas Rivers stated “it is obvious that Koch’s postulates have not been satisfied in viral diseases.
That being so, how are these so called “virus’s being tested. 1936 was a fair time ago.
( From an article by Jon Rapport 24/4/2020 )
Cool theyll die Sone enough
[…] Source: https://expose-news.com/2024/12/07/big-pharma-collborates-with-uk-government/ […]